Paul Po-Jen Yeung

Title: Paul Po-Jen Yeung: Innovator in Autism Treatment

Introduction

Paul Po-Jen Yeung is an accomplished inventor based in Southeastern, PA (US). He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of autism spectrum disorder. His innovative approach has led to the development of a unique compound aimed at alleviating symptoms associated with autism.

Latest Patents

Yeung holds a patent for "Carbamoyl cyclohexane derivatives for treating autism spectrum disorder." This invention relates to trans-N-[4-[2-[4-(2,3-dichlorophenyl)piperazin-1-yl]ethyl]cyclohexyl]-N',N'-dimethylurea (cariprazine), along with its salts, close analogs, derivatives, pharmaceutical compositions, metabolites, and combinations. The primary objective of this invention is to treat one or more symptoms of autism. Additionally, cariprazine has been found suitable for treating conditions such as Asperger's syndrome, atypical autism, Rett syndrome, childhood disintegrative disorder, attention deficit hyperactivity disorder (ADHD), and sensory integration dysfunction. Yeung's patent portfolio includes 1 patent.

Career Highlights

Yeung is currently associated with Richter Gedeon Nyrt., where he continues to work on innovative solutions in the pharmaceutical industry. His dedication to research and development has positioned him as a key player in the field of autism treatment.

Collaborations

Throughout his career, Yeung has collaborated with notable colleagues, including Viktor Román and Nika Adham-Parangi. These partnerships have fostered a collaborative environment that enhances the potential for groundbreaking discoveries.

Conclusion

Paul Po-Jen Yeung is a pioneering inventor whose work in autism treatment is making a significant impact. His innovative patent and ongoing research efforts contribute to the advancement of therapeutic options for individuals with autism spectrum disorder.